Boehringer Ingelheim (Austria)
Parent institution Boehringer Ingelheim (Germany)
ROR: Yes
Works count: 1,029
Citations count: 46,960
Molecular requirements for epithelial–mesenchymal transition during tumor progression
2005 · Margit A. Huber, Norbert Kraut, et al. · Current Opinion in Cell Biology
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
2017 · Norman Sachs, Joep de Ligt, et al. · Cell
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
2008 · D Li, Lauren Ambrogio, et al. · Oncogene